Human lymphocyte antigen DR7 protects against proliferative retinopathy with type II diabetes mellitus

Archives of Medical Research

Volumn 33, Issue 2, 2002, Pages 123-127

  Quiroz Mercado, Hugo ^a,c   Suárez Licona, Ana ^a   Fromow Guerra, Jans ^a   López Carasa, Gabriela ^a   Cárdenas Hernández, Rubén ^a   Ruiz Morales, Jorge A ^b   Portal Celhay, Cynthia ^b   Granados, Julio ^b  

^a Asociacion para Evitar la Ceguera en Mexico IAP   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c HOSPITAL DR LUIS SÁNCHEZ BULNES   (Mexico)

Author keywords

Diabetic retinopathy; Human lymphocyte antigen; Non insulin dependent diabetes mellitus

Indexed keywords

HLA D ANTIGEN; HLA DR11 ANTIGEN; HLA DR7 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; DNA EXTRACTION; DNA HYBRIDIZATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; GENE AMPLIFICATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; HLA-DR7 ANTIGEN; HUMANS; LYMPHOCYTES; MALE; MEXICO; MIDDLE AGED;

EID: 0036119710     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-4409(01)00378-2     Document Type: Article

References (30)

1. Incidence of type II diabetes in Mexican Americans
2. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity and body-fat distribution
3. Opportunities for cost reduction in diabetic retinopathy treatment: Case study from Mexico
4. Diabetes in Mexico a serious and growing problem
5. Genetic and environmental determinants of type II diabetes in Mexico City and San Antonio
6. Pericytes in diabetic retinopathy
7. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study
8. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study (ETDRS) Report 18
9. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22
10. Adherence to treatment and social support in patients with non-insulin dependent diabetes mellitus
11. Diabetes mellitus
12. Risk factors for diabetic retinopathy among Saudi diabetics
13. Autoimmunity and the outer retina
14. Genetic susceptibility to the development of retinopathy in insulin-dependent diabetics
15. Histocompatibility antigen frequencies in diabetic retinopathy
16. Frecuencia y oportunidad del diagnóstico en retinopatía diabética
17. Immunohistopathologic findings in proliferative diabetic retinopathy
18. HLA-DQB1*0201/0302 is associated with severe retinopathy in patients with IDDM
19. HLA-A, B, C, DR, Bf, and C2 alleles in insulin-dependent diabetes mellitus with proliferative retinopathy
20. A review of HLA antigens in longstanding IDDM with and without severe retinopathy
21. HLA-markers et retinopathy du diabétique dans la population sénégalaise
22. Prevalence and risk factors for diabetic retinopathy among Omani diabetics
23. Development and progression of diabetic retinopathy in Koreans with NIDDM
24. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene
25. Genetic structure of IDDM1: Two separate regions in the major histocompatibility complex contribute to susceptibility or protection
26. Analysis of tumor necrosis factor-alpha promoter polymorphism in type 1 diabetes: HLA-band DRB1 alleles are primarily associated with the disease in Japanese
27. Tumor necrosis factor-alpha induced insulin resistance in adipocytes
28. Rapid DNA isolation for enzymatic and hybridization analysis
29. Exon 2 DNA sequence of the Drw13b allele obtained from genomes of five different individuals